Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+34.1%
5Y CAGR+18.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+34.1%/yr
vs +0.8%/yr prior
5Y CAGR
+18.4%/yr
Recent acceleration
Acceleration
+33.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.98M | +19.3% |
| 2024 | $10.88M | +67.9% |
| 2023 | $6.48M | +20.4% |
| 2022 | $5.38M | +2.0% |
| 2021 | $5.28M | -5.4% |
| 2020 | $5.58M | +1.4% |
| 2019 | $5.50M | +5.5% |
| 2018 | $5.21M | +46.7% |
| 2017 | $3.55M | +72.7% |
| 2016 | $2.06M | - |